Totals
- Total revenue
- $28,903,115
- Total expenses
- $31,448,930
- Contributions and grants received
- $26,098,672
- Grants paid
- $0
- Program service revenue
- $1,749,804
- Investment income
- $700,573
- Other revenue
- $354,066
- Total assets, end of year
- $36,656,603
- Total liabilities, end of year
- $12,690,938
- Net assets or fund balances, end of year
- $23,965,665
- Program services expenses (Part IX)
- $26,304,298
- Management and general expenses
- $5,144,632
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $26,304,298
Program services were 83.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1e · Government grants (contributions)
$8,464,406
-
1f · All other contributions, gifts and grants
$17,634,266
-
1g · Noncash contributions included above
$15,000,000
-
2a · Program service revenue: DRUG DISCOVERY
total $1,276,306 · related or exempt $1,276,306
-
2b · Program service revenue: BASIC SCIENCES
total $250,000 · related or exempt $250,000
-
2c · Program service revenue: CLINICAL SCIENCES
total $223,498 · related or exempt $223,498
-
3 · Investment income
total $672,185 · excluded $672,185
-
7a · Gross sales of assets other than inventory
securities $18,480,636 · other assets $50,000
-
7b · Less cost or other basis and sales expenses
securities $18,468,061 · other assets $34,187
-
7c · Gain or loss
securities $12,575 · other assets $15,813
-
7d · Net gain or loss
total $28,388 · excluded $28,388
-
11a · Other revenue: TAX REFUND
total $324,143 · excluded $324,143
-
11b · Other revenue: LAB SERVICES INCOME
total $18,444 · excluded $18,444
-
11c · Other revenue: VIVARIUM INCOME
total $11,479 · excluded $11,479
-
11e · Other revenue, total
$354,066
Functional expenses
Part IX, the statement of functional expenses.
-
5 · Compensation of officers, directors and key employees
total $2,410,907 · program services $1,587,920 · management and general $822,987
-
7 · Other salaries and wages
total $11,689,439 · program services $10,154,142 · management and general $1,535,297
-
8 · Pension plan contributions
total $490,805 · program services $394,308 · management and general $96,497
-
9 · Other employee benefits
total $1,486,508 · program services $1,185,292 · management and general $301,216
-
10 · Payroll taxes
total $909,441 · program services $712,934 · management and general $196,507
-
11b · Fees: legal
total $96,806 · program services $47,336 · management and general $49,470
-
11c · Fees: accounting
total $60,550 · management and general $60,550
-
11d · Fees: lobbying
total $105,000 · management and general $105,000
-
11g · Fees: other
total $1,168,564 · program services $882,135 · management and general $286,429
-
12 · Advertising and promotion
total $42,544 · management and general $42,544
-
13 · Office expenses
total $1,235,559 · program services $1,024,670 · management and general $210,889
-
14 · Information technology
total $330,588 · program services $159,680 · management and general $170,908
-
16 · Occupancy
total $3,159,671 · program services $2,468,301 · management and general $691,370
-
17 · Travel
total $264,834 · program services $209,321 · management and general $55,513
-
19 · Conferences, conventions and meetings
total $62,178 · program services $36,952 · management and general $25,226
-
22 · Depreciation, depletion and amortization
total $1,174,765 · program services $1,089,014 · management and general $85,751
-
23 · Insurance
total $74,419 · management and general $74,419
-
24a · Other expenses: OTHER LAB EXPENSES
total $2,629,777 · program services $2,486,502 · management and general $143,275
-
24b · Other expenses: GENERAL LAB SUPPLIES
total $2,093,345 · program services $2,093,345
-
24c · Other expenses: LAB SERVICES
total $1,528,782 · program services $1,528,199 · management and general $583
-
24d · Other expenses: OTHER EXPENSES
total $297,306 · program services $244,247 · management and general $53,059
-
24e · All other expenses
total $137,142 · management and general $137,142
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $1,818,627 · end of year $1,607,216
-
2 · Savings and temporary cash investments
beginning of year $874,880 · end of year $937,502
-
4 · Accounts receivable
beginning of year $2,029,964 · end of year $1,733,028
-
9 · Prepaid expenses and deferred charges
beginning of year $522,545 · end of year $579,766
-
10a · Land, buildings and equipment: cost or other basis
$25,460,121
-
10b · Land, buildings and equipment: accumulated depreciation
$20,768,464
-
10c · Land, buildings and equipment, net
beginning of year $3,199,498 · end of year $4,691,657
-
11 · Investments: publicly traded securities
beginning of year $20,059,283 · end of year $18,259,016
-
12 · Investments: other securities
beginning of year $2,431,210 · end of year $2,431,210
-
15 · Other assets
beginning of year $170,203 · end of year $6,417,208
-
17 · Accounts payable and accrued expenses
beginning of year $3,329,562 · end of year $2,912,707
-
19 · Deferred revenue
beginning of year $1,198,822 · end of year $1,160,422
-
25 · Other liabilities
beginning of year $1,272,830 · end of year $8,617,809
-
27 · Net assets without donor restrictions
beginning of year $24,310,645 · end of year $22,987,039
-
28 · Net assets with donor restrictions
beginning of year $994,351 · end of year $978,626
Mission and programs · 2022
Mission
THE MISSION OF THE INSTITUTE IS TO TRANSLATE BASIC GENETIC AND MOLECULAR MECHANISMS OF SCHIZOPHRENIA AND RELATED DEVELOPMENTAL BRAIN DISORDERS INTO CLINICAL ADVANCES THAT CHANGE THE LIVES OF AFFECTED INDIVIDUALS. IT IS CATALYZING A NEW UNDERSTANDING OF BRAIN DISEASE BY LINKING ADVANCES IN THE CONSTRUCTION AND FUNCTION OF THE HUMAN BRAIN WITH THE DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES.
-
CLINICAL SCIENCES: THE CLINICAL SCIENCE DIVISION INVESTIGATES MECHANISMS OF SCHIZOPHRENIA AND RELATED BRAIN DISORDERS IN CLINICAL STUDIES AND IN BIOLOGICAL MATERIAL FROM CLINICAL SAMPLES SPECIFICALLY ASCERTAINED, EVALUATED AND MANAGED BY INSTITUTE STAFF AND THROUGH COLLABORATIONS WITH JOHNS HOPKINS UNIVERSITY, THE NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH), UNIVERSITY OF BARI (ITALY), MEDICAL COLLEGE OF VIRGINIA, MORGAN STATE UNIVERSITY AND OTHERS.
Expenses $4,645,870 · Revenue $223,498
-
BASIC SCIENCES: THE CREATION OF MODEL SYSTEMS AT THE INSTITUTE TO STUDY PSYCHIATRIC ILLNESS IS THE MAJOR GOAL OF THE BASIC SCIENCES RESEARCH PROGRAM. USING OUR UNIQUE COLLECTION OF HUMAN BRAIN MATERIAL AND INDUCED PLURIPOTENT STEM CELL LINES, WE ARE DEFINING THE MOLECULAR SIGNATURE OF DISEASE RISK. TO PROVIDE THE BASIS FOR THERAPEUTIC INTERVENTION WE ARE DEVELOPING NEW TECHNOLOGIES USING HUMAN STEM CELLS TO IDENTIFY THE FUNCTIONAL CONSEQUENCES OF GENETIC RISK FACTORS. THE GOAL OF THESE STUDIES IS THE IDENTIFICATION OF THERAPEUTIC TARGETS BASED ON THE MECHANISMS OF DISEASE.
Expenses $16,070,140 · Revenue $250,000
-
DRUG DISCOVERY: IMPROVED GENETIC UNDERSTANDING OF DISEASES OF BRAIN DEVELOPMENT IS REVEALING NEW DRUG DISCOVERY OPPORTUNITIES. GUIDED BY GENETICS, THE INSTITUTE'S DRUG DISCOVERY DIVISION IS INVESTIGATING NEW TARGETS FOR PSYCHIATRIC DISEASES, WITH THE GOAL OF VALIDATING INNOVATIVE APPROACHES THAT WILL LEAD TO NOVEL MEDICINES FOR PATIENTS SUFFERING FROM THESE CONDITIONS. THE DRUG DISCOVERY DIVISION MAINTAINS A STATE OF THE ART MEDICINAL CHEMISTRY LABORATORY AND UNIQUE CAPABILITIES IN TARGET VALIDATION.
Expenses $5,588,288 · Revenue $1,276,306
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Herbert Pardes MDHERBERT PARDES MD
CHAIRMAN OF THE BOARD
- Total calculated
- $0
- Hours/week
- 1
-
Steven S Sharfstein MDSTEVEN S SHARFSTEIN MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Paul B Rothman MDPAUL B ROTHMAN MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Geoffrey SimonGEOFFREY SIMON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Mary RubinMARY RUBIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Tamar MaltzTAMAR MALTZ
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Milton MaltzMILTON MALTZ
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Robert MuseROBERT MUSE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Daniel R GettsDANIEL R GETTS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Landon S KingLANDON S KING
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Daniel R WeinbergerDANIEL R WEINBERGER
CEO & DIRECTOR
- Total calculated
- $789,762
- From this org
- $763,001
- From related orgs
- $0
- Other
- $26,761
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $675,444
- Bonus
- $86,939
- Other
- $618
- Deferred
- $10,250
- Nontaxable benefits
- $16,511
- Filer's total
- $789,762
-
Thomas Michael HydeTHOMAS MICHAEL HYDE
CHIEF MEDICAL OFFICER
- Total calculated
- $438,154
- From this org
- $411,393
- From related orgs
- $0
- Other
- $26,761
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $390,934
- Bonus
- $19,735
- Other
- $724
- Deferred
- $10,250
- Nontaxable benefits
- $16,511
- Filer's total
- $438,154
-
Elaine JonesELAINE JONES
CHIEF OPERATING OFFICER
- Total calculated
- $425,085
- From this org
- $414,835
- From related orgs
- $0
- Other
- $10,250
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $393,284
- Bonus
- $3,650
- Other
- $17,901
- Deferred
- $10,250
- Nontaxable benefits
- $0
- Filer's total
- $425,085
-
Andrew MaslanANDREW MASLAN
CFO & TREASURER
- Total calculated
- $379,485
- From this org
- $347,452
- From related orgs
- $0
- Other
- $32,033
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $344,176
- Bonus
- $3,000
- Other
- $276
- Deferred
- $10,250
- Nontaxable benefits
- $21,783
- Filer's total
- $379,485
-
James BarrowJAMES BARROW
ASSOC. DIR. OF DRUG DISCOV
- Total calculated
- $369,107
- From this org
- $337,058
- From related orgs
- $0
- Other
- $32,049
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $291,066
- Bonus
- $45,716
- Other
- $276
- Deferred
- $10,250
- Nontaxable benefits
- $21,799
- Filer's total
- $369,107
-
Joel E KleinmanJOEL E KLEINMAN
ASSOC. DIR. OF CLINICAL SC
- Total calculated
- $424,219
- From this org
- $397,458
- From related orgs
- $0
- Other
- $26,761
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $377,105
- Bonus
- $19,735
- Other
- $618
- Deferred
- $10,250
- Nontaxable benefits
- $16,511
- Filer's total
- $424,219
-
Brady MaherBRADY MAHER
LEAD INVESTIGATOR
- Total calculated
- $244,257
- From this org
- $213,151
- From related orgs
- $0
- Other
- $31,106
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $176,268
- Bonus
- $36,703
- Other
- $180
- Deferred
- $9,307
- Nontaxable benefits
- $21,799
- Filer's total
- $244,257
-
Shizhong HanSHIZHONG HAN
LEAD INVESTIGATOR, DATA SC
- Total calculated
- $227,935
- From this org
- $197,004
- From related orgs
- $0
- Other
- $30,931
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $156,104
- Bonus
- $40,780
- Other
- $120
- Deferred
- $9,148
- Nontaxable benefits
- $21,783
- Filer's total
- $227,935
-
Keri MartinowichKERI MARTINOWICH
LEAD INVESTIGATOR
- Total calculated
- $235,093
- From this org
- $203,954
- From related orgs
- $0
- Other
- $31,139
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $179,525
- Bonus
- $24,249
- Other
- $180
- Deferred
- $9,340
- Nontaxable benefits
- $21,799
- Filer's total
- $235,093
-
Gregory CarrGREGORY CARR
LEAD INVESTIGATOR
- Total calculated
- $222,754
- From this org
- $191,487
- From related orgs
- $0
- Other
- $31,267
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $148,964
- Bonus
- $42,403
- Other
- $120
- Deferred
- $9,468
- Nontaxable benefits
- $21,799
- Filer's total
- $222,754
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 1a · Housing allowance or residence for personal use
- 2 · Substantiation required before reimbursing expenses
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 1b · Written policy on the line-1a expenses
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 1A
- PAYMENTS FOR BUSINESS USE OF PERSONAL RESIDENCE: THE INSTITUTE RENTS AN APARTMENT IN BALTIMORE, MD FOR IT'S COO, ELAINE JONES, WHO COMMUTES WEEKLY FROM CAPE CHARLES, VIRGINIA. A DAILY COMMUTE FROM CAPE CHARLES, VA IS OVER 200 MILES EACH WAY, TOO GREAT OF A DISTANCE TO EXPECT A REASONABLE DAILY COMMUTE.
- PART I, LINE 1B
- THE INSTITUTE PROVIDED PERSONAL HOUSING AS PART OF A NEGOTIATED COMPENSATION AND BENEFITS PACKAGE. THE INSTITUTE DID NOT ANTICIPATE REPEATING THIS ARRANGEMENT, AND THEREFORE DID NOT ESTABLISH A POLICY GOVERNING THIS TYPE OF ARRANGEMENT.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $0
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | IP LICENSING | DRUG DISCOVERY | — |
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 22 December 2023
- IRS schema version
- 2022v5.0
- Source object
- 202303569349301010
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.